ETH 446
Pill imprint ETH 446 has been identified as Oxycodone hydrochloride 30 mg.
Oxycodone is used in the treatment of pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy.
Oxycodone 30 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Oxycodone hydrochloride Images
- Imprint:
-
ETH
446 - Strength:
- 30 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
silicon dioxide
stearic acid
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0446
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5390 | Physicians Total Care Inc (repackager) |
| 66336-0135 | Dispensing Solutions Inc. (repackager) |
| 16590-0671 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Oxycodone Hydrochloride resources
- Oxycodone
- Oxycodone (Wolters Kluwer)
- Oxycodone Concentrate (Wolters Kluwer)
- Oxycodone Solution (Wolters Kluwer)
- Oxycodone Sustained-Release Tablets (Wolters Kluwer)
- oxycodone (Cerner Multum)
- Oxy IR (Micromedex) - Includes Dosage Information
- Oxycontin CR (Micromedex) - Includes Dosage Information
- oxycodone (Micromedex) - Includes Dosage Information
- Oxycodone (AHFS DI)
- Oxycodone Hydrochloride (AHFS DI)
- Oxycodone (FDA)
- Oxycodone Capsules (FDA)
- Oxycodone ER (FDA)
- Oxycodone Extended-Release Tablets (FDA)
- Oxycodone Immediate-Release Capsules (FDA)
- Oxycodone Solution (FDA)
- Oxycodone Solution Concentrate (FDA)
- Oxycodone Hydrochloride (Wolters Kluwer)
Search Again
